DIRECT BIOLOGICS LLC

In News

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - BioInformant

BioInformant - Jul 13, 2023

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - Newswire.com

Newswire.com - Jan 12, 2021

Rapid Micro Biosystems Announces Follow-on Multi-System - GlobeNewswire

GlobeNewswire - Mar 12, 2026

Direct Biologics - The Pharma Letter

The Pharma Letter - Jun 30, 2024

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo™ - BioInformant

BioInformant - Aug 02, 2020

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - PR Newswire

PR Newswire - Dec 12, 2025

Finding Irreparable Harm: 5th Circuit Vacates Refusal to Enter Preliminary Injunction - McGuireWoods

McGuireWoods - Apr 28, 2023

Tr1 Treg Therapy to be Evaluated in Trial for Crohn Disease - CGTLive®

CGTLive® - Aug 11, 2024

APEX Biologix, LLC Announces Agreement With New Exosome Supplier - Newswire.com

Newswire.com - Sep 19, 2019

Direct Biologics Receives FDA Approval to Proceed with Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome - BioInformant

BioInformant - Jun 09, 2021

Biologics and DTC: Mainstream ad campaigns now price of admission for biologic brands - Fierce Pharma

Fierce Pharma - Jan 28, 2020

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment